5 results
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
should prevent the disease ... Preferred Management ... 500–1000 mg PO BID ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
Doxycycline 100 mg PO BID ... consultation to guide management ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Preventing CMV Disease ... CMV end-organ disease ... Valganciclovir 900 mg PO BID ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Severe Disseminated Disease ... for 3 days, then BID ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Disseminated MAC Disease ... Clarithromycin 500 mg PO BID ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology